SWITZERLAND: NOVARTIS SCIENTIFIC SERVICE SPINOFF

Article Abstract:

The Swiss chemicals group Novartis is hiving off its scientific services operations with effect from 1 October 1999. The new Basle-based company called Solvias AG is owned almost 50% by the management, which was supported by Novartis Venture Fund. Solvias will offer services increasingly to clients outside the Novartis group, although Novartis and Ciba Spezialitatenchemie will remain the main clients. Currently business with third parties accounts for about one-third of the turnover that should be around SFr 35mn-40mn. In regional terms, Solvias' focus will be on Europe. Solvias spends about 10% of turnover on R&D, with the main targets being catalysis, synthesis, surface characterisation, on-line spectroscopy and new analytic methods.

Research & development outlays, Research & Development, Scientific Research and Development Services, Chemicals & Allied Products, Chemical Manufacturing, Research institutes, Chemicals, Novartis AG

---

GERMANY: APL LOGISTICS TAKES CONTROL OF MARE LOGISTIK

Article Abstract:

APL Logistics (APLL) is taking over German Hamburg-based Mare Logistik GmbH, a transport and logistics company. With 30 staff, Mare generates an annual turnover of DM 140mn. APLL, a subsidiary of Neptune Orient Lines (NOL) of Singapore, is strengthening its activities in end-to-end supply chain management.

Germany, Neptune Orient Lines Ltd., APL Logistics, Mare Logistik GmbH

---

SWITZERLAND: DANZAS CHEMICALS FOR SALE

Article Abstract:

Danzas is in talks about selling Danzas Chemicals. The Swiss subsidiary of Deutsche Post AG is to withdraw from the transport of chemical bulk goods, which employs 285 staff and generates an annual turnover of about European 120mn.

Deutsche Post AG

Similar abstracts:

• Abstracts: SWITZERLAND: MADER EXPAND SYNTHETIC RESIN OUTPUT. GERMANY: BASF UPS GRANULE OUTPUT
• Abstracts: GERMANY: FCM PRESENTS 200-MM GAAS WAFER. GERMANY: MICROELECTRONICS R&D WITH MOTOROLA. Germany: FCM cuts staff
• Abstracts: GERMANY: DIABETES, TREATMENT COSTS. GERMANY: INVESTMENTS BY BIOTEST. GERMANY: INSULIN PRODUCTION BY DIABEL
• Abstracts: GERMANY: DIABETES, TREATMENT COSTS. GERMANY: SEPTIC SHOCK IN 1999. WESTERN WORLD: IRRITABLE BOWEL SYNDROME
• Abstracts: Caprolactam: Neues Verfahren GERMANY: ETHYLENE INVESTMENT BY ERDOLCHEMIE. GERMANY: DOW CONSIDERING NEW CRACKER

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.